Pfizer announces $130 million investment in two Irish manufacturing sites

New specialist high-tech capability to be developed at Ringaskiddy; production expansion at Grange Castle creating 250 construction jobs

 

Pfizer today announces that $130 million is being invested in two of its Irish manufacturing sites.  $100 million is being invested in the Grange Castle site in Dublin and $30 million is being invested in the Ringaskiddy site in Cork. 


The investments, which are supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland, will enable the sites to expand their capacity and begin producing more advanced, complex therapies to deal with some of the most devastating and difficult to cure diseases.

Read full release here